Search

Displaying results 1431 - 1440 of 10000 in total
  1. Drug

    Eribulin

    go.drugbank.com/drugs/DB08871
    ApprovedInvestigational

    Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic

    Products: HALAVEN 0.5 mg/ml solution for injection, Eribulin Advanz Pharma 0,44 mg/ml Injektionslösung
  2. Drug

    PHI-101

    go.drugbank.com/drugs/DB17237
    Investigational

  3. Drug

    SUN-101

    go.drugbank.com/drugs/DB17238
    Investigational

  4. Drug

    TALL-104

    go.drugbank.com/drugs/DB17360
    Investigational

    Synonyms: TALL 104, Human major histocompatibility complex (MHC) non-restricted T-cell line 104
  5. Drug

    NZ-1002

    go.drugbank.com/drugs/DB17688
    Experimental

    Synonyms: NZ 1002, NZ-1002
  6. Drug

    NT-102

    go.drugbank.com/drugs/DB18112
    Experimental

  7. Drug

    AP-102

    go.drugbank.com/drugs/DB18206
    Experimental

    Synonyms: L-threoninamide, 4-amino-3-iodo-d-phenylalanyl-l-cysteinyl-3-iodo-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2->7)-disulfide
  8. Drug

    ET-101

    go.drugbank.com/drugs/DB18255
    Experimental

  9. Drug

    LX-1004

    go.drugbank.com/drugs/DB18272
    Experimental

  10. Drug

    TSHA-101

    go.drugbank.com/drugs/DB18280
    Investigational